WallStreetZenWallStreetZen

NASDAQ: AYTU
Aytu Biopharma Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

AYTU past revenue growth

How has AYTU's revenue growth performed historically?
Company
-6.71%
Industry
10.23%
Market
16.96%
AYTU's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AYTU's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AYTU's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AYTU earnings and revenue history

Current Revenue
$98.5M
Current Earnings
-$18.0M
Current Profit Margin
-18.3%

AYTU Return on Equity

Current Company
-49.5%
Current Industry
15.4%
Current Market
188%
AYTU's Return on Equity (-49.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AYTU announces earnings.

AYTU Return on Assets

Current Company
-13.1%
Current Industry
3.4%
AYTU is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AYTU Return on Capital Employed

Current Company
-25.6%
Current Industry
5.1%
AYTU's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AYTU vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AYTU$98.50M-$8.45M-$18.00M+83.31%N/A
RDHL$6.53M$14.62M$23.92M-4.82%N/A
TLPH$651.00k-$17.95M-$18.40M-21.26%N/A
FLGC$76.07M-$55.40M-$56.35M+894.89%N/A
KALA$0.00-$35.91M-$42.20M-100.00%N/A
View Top Pharmaceutical Stocks

AYTU earnings dates

Next earnings date
May 17, 2024

Aytu Biopharma Earnings & Revenue FAQ

What were AYTU's earnings last quarter?

On Invalid Date, Aytu Biopharma (NASDAQ: AYTU) reported Q4 2023 earnings per share (EPS) of -$0.04, up 98.14% year over year. Total Aytu Biopharma earnings for the quarter were -$220.00 thousand. In the same quarter last year, Aytu Biopharma's earnings per share (EPS) was -$2.15.

If you're new to stock investing, here's how to buy Aytu Biopharma stock.

What was AYTU's earnings growth in the past year?

As of Q2 2024, Aytu Biopharma's earnings has grown year over year. Aytu Biopharma's earnings in the past year totalled -$18.00 million.

What is AYTU's earnings date?

Aytu Biopharma's earnings date is Invalid Date. Add AYTU to your watchlist to be reminded of AYTU's next earnings announcement.

What was AYTU's revenue last quarter?

On Invalid Date, Aytu Biopharma (NASDAQ: AYTU) reported Q4 2023 revenue of $22.93 million up 12.73% year over year. In the same quarter last year, Aytu Biopharma's revenue was $26.28 million.

What was AYTU's revenue growth in the past year?

As of Q2 2024, Aytu Biopharma's revenue has grown -6.71% year over year. This is 16.93 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.23%. Aytu Biopharma's revenue in the past year totalled $98.50 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.